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Abstract In parasitism, Plasmodium falciparum is exposed to
toxic reactive oxygen species and reactive nitrogen species
(RNS). Peroxiredoxins (Prx) are ubiquitously distributed anti-
oxidant enzymes. In bacteria and yeast, Prx have also been
implicated in detoxifying RNS. Here, we used a gene targeting
strategy to investigate the physiological role of 2-Cys Prx of
P. falciparum, PfTPx-1, in living parasite cells. The PfTPx-1-
null parasite line was more sensitive to paraquat (a superoxide
donor) and sodium nitroprusside (a nitric oxide donor), than
wildtype. These ¢ndings suggest that PfTPx-1 protects the par-
asite cells from oxidative and nitrosative stresses.
* 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Plasmodium falciparum is the parasitic pathogen that causes
falciparum malaria, one of the most debilitating and life-
threatening diseases in tropical regions of the world. Despite
years of intensive research, an e¡ective vaccine is still not
available, and the parasite displays increasing resistance to-
wards the commonly used plasmodicidal drugs. To combat
falciparum malaria, a better understanding of the basic biol-
ogy of P. falciparum, especially the mechanism of adaptation
to environmental conditions, is needed.
P. falciparum lives in an oxygen- and nitrogen-rich environ-
ment in humans and is exposed to toxic reactive oxygen spe-
cies (ROS) and reactive nitrogen species (RNS). When the
parasite infects erythrocytes, it is exposed to superoxide
(O32 ) and nitric oxide (NO) from the host immune system
[1]. Because hemoglobin has a high a⁄nity for NO, the para-
site would likely be exposed to NO derivatives in erythrocytes
[2]. In addition, O32 and pro-oxidative heme iron are produced
by the parasite when it digests hemoglobin for nutrition [3].
The signi¢cant decrease in glutathione (GSH) in parasite-in-
fected erythrocytes suggests that the parasites need e⁄cient
antioxidant systems [4,5]. P. falciparum has been shown re-
cently to possess two major functional antioxidant systems: a
thioredoxin system [5^7] and a glutathione system [5,8]. To
date, an enzymatic defense against RNS has not been identi-
¢ed in P. falciparum.
Peroxiredoxins (Prx) are a family of antioxidants that are
found in all organisms from bacteria to humans [9,10]. Align-
ment of the amino acid sequences among this family of pro-
teins revealed the existence of two types of Prx, which di¡er in
the number of conserved cysteine residues. The 2-Cys Prx
contains both conserved residues (Cys47 and Cys170), where-
as the 1-Cys group lacks the Cys170 residue [9,11,12]. Several
Prx proteins act as terminal peroxidases which reduce hydro-
gen peroxide and organic hydroperoxides using electrons do-
nated by the thioredoxin system [9] and other physiological
reductants [11,12]. 2-Cys Prx have also been implicated in
detoxifying RNS in bacteria [13] and yeast [14].
In P. falciparum, we and other groups have reported three
Prx subfamilies (reviewed in [7]). It was suggested that these
Prx subfamilies in P. falciparum be named Pf1-Cys-Prx,
PfTPx-1, and PfTPx-2 [7]. PfTPx-1 is the 2-Cys Prx, which
contains two VCP motifs [15^17]. The PfTPx-1 protein is ex-
pressed during the trophozoite stage [15]. Recombinant
PfTPx-1 protein showed peroxidase activities when H2O2,
t-butylhydroperoxide, and cumene hydroperoxide are avail-
able as substrates [15^17] and was suggested to be the termi-
nal peroxidase in the thioredoxin (Trx)/Trx reductase (TrxR)
system during the intraerythrocytic stage [15^18].
In the present study, we investigated if PfTPx-1 acts as an
antioxidant in parasite cells and detoxi¢es ROS and RNS with
a targeted gene disruption strategy.
2. Materials and methods
2.1. Parasite culture
The FCR-3 strain of P. falciparum was cultured with a modi¢cation
of the method of Trager and Jensen [19] and synchronized with 5%
D-sorbitol [20].
2.2. PfTPx-1 gene disruption construct
For disruption of the PfTPx-1 gene, a 545-bp fragment correspond-
ing to nucleotides 3^527 of the coding region was ampli¢ed by poly-
merase chain reaction (PCR). The primers used were 5P-GCG
GCG GCC GCG GCA TCA TAT GTA GG-3P and 5P-GCG
GGA TCC TTT TTC CAG TTT GCT GGG CA-3P. The primers
contained a NotI site and BamHI site (underlined), respectively, for
cloning of the PCR product into pDT.Tg23 [21] (MRA-97, Malaria
Research and Reference Reagent Resource (MR4) Center, Manassas,
VA, USA), a kind gift of Y. Wu and T.E. Wellems (National Institute
of Allergy and Infectious Diseases, National Institutes of Health,
Bethesda, MD, USA). pDT.Tg23 contains the dihydrofolate reduc-
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tase-thymidylate synthase (DHFR-TS) gene of Toxoplasma gondii,
which confers resistance to pyrimethamine to transfectants. The plas-
mid construct made in this study was named pDT.Tg23 TPx-1 KO.
2.3. Transformation and selection of parasite lines
Parasites were transfected with 100 Wg of pDT.Tg23 TPx-1 KO
DNA by electroporation as described previously [22]. In brief, 109
erythrocytes with 5% parasitemia of ring-stage parasites were trans-
fected with vector DNA in incomplete Cytomix solution [22]. The
Gene Pulsar II system (Bio-Rad) was used at 0.31 kV and 975 WF.
Drug selection with 1 WM pyrimethamine was initiated 48 h after
electroporation, and this concentration was used thereafter. Trans-
formed parasites grew slowly immediately after the start of drug se-
lection. Continuous culture resulted in an increased growth rate, sug-
gesting that episomally transformed parasites had been replaced by
parasites in which the plasmid construct was integrated into the ge-
nome [23]. Ten weeks after the transformation, the integration of the
plasmid construct into the targeted locus was detected by Southern
hybridization analysis (described below). Single-cell clones were ob-
tained by limiting dilution after integration was veri¢ed. As a control
for transfection and selection, empty pDT.Tg23 plasmid was electro-
porated into parasites under the same conditions used for pDT.Tg23
TPx-1 KO. Drug selection with 1 WM pyrimethamine was initiated
48 h after electroporation, and this concentration was used thereafter.
Twelve weeks after transfection, the growth rate of pDT.Tg23-trans-
formants had increased as much as that of pDT.Tg23 TPx-1 KO. This
transfectant was used as a control in the assay of parasite sensitivities
to ROS and RNS.
2.4. Southern blot analysis
Genomic DNA used for Southern blot analysis was extracted from
parasite-infected erythrocytes by the standard phenol^chloroform
method [24]. For Southern blot analysis, genomic DNA was triply
restricted with NotI, BamHI, and HindIII. Digested DNAs were sep-
arated by agarose gel electrophoresis and transferred onto HiBond
Nþ membranes (Amersham Pharmacia Biotech). The membrane was
probed with the entire coding sequence of PfTPx-1. Labeling of the
DNA probe, hybridization, and chemiluminescent signal detection
were performed with the AlkPhos direct system (Amersham Pharma-
cia Biotech).
2.5. Northern blot analysis
For Northern blot analysis, the parasite-infected erythrocytes were
harvested from the synchronized culture when the parasite reached the
late trophozoite stage. The parasite-infected erythrocytes were lysed
with phosphate-bu¡ered saline (PBS) containing 0.05% saponin. The
parasite pellet was washed several times with PBS and treated for
total RNA extraction with TRIzol reagent (Gibco Invitrogen). Five
microgram of total RNA was subjected to electrophoresis in a 1.5%
agarose^formaldehyde gel and transferred to HiBond Nþ membranes
(Amersham Pharmacia Biotech) by the standard capillary method
[24]. The membrane was probed with the entire coding sequence of
PfTPx-1. Labeling of the DNA probe, hybridization, and chemilumi-
6
Fig. 1. Design and experimental veri¢cation of PfTPx-1 gene disrup-
tion in P. falciparum. A: Design of disruption construct pDT.Tg23
TPx-1 KO, schematic of the PfTPx-1 locus, and organization fol-
lowing the single crossover homologous recombination event. The
partial open reading frame (ORF) between nt 3 and 525 of PfTPx-1
(darkly shaded region) was PCR-ampli¢ed and cloned into the
NotI/BamHI sites of the original plasmid (pDT.Tg23). The vector
contains the T. gondii DHFR-TS gene as a selectable marker (open
box). hrp, histidine-rich protein. The restriction sites used to verify
the integration event are indicated on the illustration (B, BamHI;
H, HindIII; N, NotI). B: Southern blot analysis of genomic DNA
samples triply digested with BamHI, HindIII, and NotI. DNA sam-
ples from wildtype (FCR-3) and the PfTPx-1 KO line were digested
and loaded onto 0.7% agarose gel and run for 4 h at 50 V in TAE
bu¡er. After electrophoresis, DNAs were transferred onto nylon
membrane and probed with the coding sequence of PfTPx-1. DNA
size markers in kb are indicated on the left. C: Northern blot analy-
sis of wildtype and the PfTPx-1 KO line. Total RNAs (5 Wg) ex-
tracted from trophozoite/schizont cultures were separated by electro-
phoresis in a 1.5% agarose^formaldehyde gel (left panel) and
probed with the coding sequence of PfTPx-1 (right panel). Ethidium
bromide-stained gel shows equal loading. Sizes in kb are indicated
on the left. D: Western blot analysis of wildtype and the PfTPx-1
KO line. Cell lysates (10 Wg) extracted from trophozoite/schizont
cultures were separated by 12.5% SDS^PAGE (left panel) and
probed with anti-PfTPx-1 rabbit serum (right panel). Coomassie
brilliant blue (CBB)-stained gel shows equal loading. Molecular
weight markers in kDa are indicated on the left.
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nescent signal detection were performed with the AlkPhos direct sys-
tem (Amersham Pharmacia Biotech).
2.6. Western blot analysis
For Western blot analysis, late trophozoite parasite pellets were
prepared by the same method as used for the Northern blot analysis
and solubilized in sodium dodecyl sulfate^polyacrylamide gel electro-
phoresis (SDS^PAGE) sample bu¡er containing 5% 2-mercaptoetha-
nol [25]. After separation by SDS^PAGE (12.5%), parasite proteins
were transferred electrophoretically to polyvinylidene di£uoride sheets
(Immobilon; Millipore) and reacted with anti-recombinant PfTPx-1
rabbit serum [15]. Immune complexes were visualized with horseradish
peroxidase-conjugated goat anti-rabbit IgG antibody (Cappel). Pro-
tein concentrations were determined with a BCA protein assay kit
(Pierce).
2.7. Assay of parasite sensitivities to ROS and RNS
To evaluate parasite sensitivity to ROS and RNS, cultures were
maintained in the presence or absence of 40 WM paraquat (Sigma)
as an O32 donor [26] and 20 WM sodium nitroprusside (SNP; Sigma)
as an NO donor [27]. Growth inhibitions by the reagents were assayed
with parasite cultures in the ring stage with initial parasitemia of
0.1%. The culture medium was replaced every 24 h, and at the same
time parasite growth was evaluated. A drop of the cultured erythro-
cytes was smeared on a slide glass and Giemsa stained. The number of
parasites in 10 000 erythrocytes was counted and de¢ned as the level
of parasitemia.
2.8. Statistical analysis
Di¡erences were evaluated using Student’s t-test. P6 0.05 was con-
sidered to be statistically signi¢cant.
3. Results and discussion
To investigate the function of PfTPx-1 in P. falciparum, the
PfTPx-1 gene was disrupted. pDT.Tg23 TPx-1 KO was trans-
fected into parasite cells, and cells that were transformed with
the plasmid construct were selected by pyrimethamine pres-
sure. After 10 weeks of selection, integration of the construct
into the PfTPx-1 locus was detected by genomic Southern
hybridization (data not shown). A clonal line with the desired
integration was established by limiting dilution. Two clonal
lines with disruptions of the PfTPx-1 locus were established.
Representative results of Southern hybridization for one
cloned line (PfTPx-1 KO) are shown in Fig. 1B. A single
21-kb signal was detected in the genome of the wildtype
(Fig. 1B). In the PfTPx-1 KO line, 12-kb and 9-kb bands
were detected on Southern blots (Fig. 1B), indicating a single
targeted integration and disruption of the PfTPx-1 locus had
occurred (Fig. 1A). No 0.5-kb band (partial open reading
frame between nt 3 and 525 of PfTPx-1; Fig. 1A) was found
to result from episomes, indicating this was lost in the clone.
Northern blotting revealed a single RNA species of about 1.4
kb, corresponding to the PfTPx-1 mRNA, in FCR-3 that was
not detectable in the PfTPx-1 KO line (Fig. 1C).
To characterize the phenotype of the PfTPx-1 KO line,
Western blot analysis with the PfTPx-1 protein-speci¢c anti-
serum was performed (Fig. 1D). Lysates of trophozoite-rich
cultures of wildtype and the PfTPx-1 KO cell line were probed
with anti-PfTPx-1 serum. A band with a molecular mass of 22
kDa, which matches the mass of PfTPx-1 [15], was detected in
wildtype lysates, whereas no band was observed in lysates of
PfTPx-1 KO cells. This result veri¢ed the PfTPx-1-null phe-
notype of the PfTPx-1 KO line.
The PfTPx-1 KO line did not di¡er from wildtype cells in
either growth rate or morphology under normal culture con-
ditions (Fig. 2A). To con¢rm if PfTPx-1 acts as an antioxi-
dant in living cells, we tested the sensitivity of PfTPx-1 KO
cells to paraquat and SNP, which produce intracellular O32
and NO respectively. The concentrations used were deter-
mined by preliminary experiments with a variety of concen-
Fig. 2. Sensitivities of the PfTPx-1 KO line to paraquat and SNP.
A: Growth curves for wildtype (FCR-3 strain, open circles), PfTPx-
1 Prx KO line (cross symbols), and pDT.Tg23 transfectant (control,
open triangles) under normal culture conditions. B: Sensitivities of
parasite lines to paraquat. Parasite lines were cultured in complete
medium containing 40 WM paraquat. C: Sensitivities of parasite
lines to SNP. Parasite lines were cultured in complete medium with
20 WM SNP. All data are meanRS.D. of three independent experi-
ments.
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trations ranging from 10 to 1000 WM (data not shown). The
PfTPx-1 KO line showed a reduced growth rate in culture
medium with 40 WM paraquat in comparison with wildtype
(day 5, P6 0.05; Fig. 2B). The growth rate of the control
transfectant showed no signi¢cant di¡erence to wildtype
under this condition. In parasite cells, superoxide anions re-
leased because of paraquat can be reduced by parasite super-
oxide dismutase [28], thereby generating H2O2 in the cyto-
plasm. It is likely that the parasite uses PfTPx-1 to reduce
this H2O2 [15^17] in connection with the Trx/TrxR system
[5^7]. In the presence of 20 WM SNP, the growth rate of the
PfTPx-1 KO line was also decreased in comparison with that
of wildtype (day 5, P6 0.05; Fig. 2C). The growth rate of the
control transfectant showed no signi¢cant di¡erence to wild-
type under this condition. These results suggest that PfTPx-1
is used for detoxifying both intracellular ROS and RNS. Be-
cause the host hemoglobin mediates delivery and capture of
NO as a vasodilator [2], the parasite is perhaps exposed to
RNS in erythrocytes. In addition, NO and its derivatives func-
tion in the host immune system to combat microbial patho-
gens [1]. Although there have been no reports of anti-RNS
activity by PfTPx-1, the peroxynitrite reductase activity,
which was recently found in the bacterial [13] and yeast [14]
2-Cys Prx subfamilies, may underlie the NO hypersensitivity
of the PfTPx-1 KO line. The parasites in erythrocytes are
most likely ¢ghting ROS and RNS, which are present in the
O32 - and NO-rich environment. Independent of these external
stresses, the parasite produces pro-oxidative heme iron in the
cell during the late trophozoite stage when it digests host
hemoglobin for nutrition [3]. Taken together these ¢ndings
suggest that the parasite must have an e⁄cient antioxidant
system to ensure intraerythrocytic development under stressful
conditions. Results from our gene targeting study suggest that
the parasite uses PfTPx-1 as a part of its antioxidant system to
detoxify intracellular ROS and RNS.
The hypersensitivity of the PfTPx-1 KO line to paraquat
and SNP compared to wildtype was not detected immediately
after the addition of each reagent into the culture medium
(Fig. 2B,C). Reduced parasite growth appeared on the third
day of the assay (48 h of culture), indicating that the toxic
e¡ects of ROS and RNS were cumulative and could only be
detected after one complete round of the parasite cell cycle.
An additional delay of culture until day 9 with 40 WM para-
quat or 20 WM SNP resulted in a further decrease of the
growth rate of FCR-3, the control transfectant, and PfTPx-
1 KO and in an increase of the di¡erence in parasitemia be-
tween FCR-3 and PfTPx-1 KO (data not shown). ROS and
RNS damage biological macromolecules via lipid peroxida-
tion and oxidation of proteins. In addition, ROS and RNS
damage DNA and are known to be powerful mutagens
[29,30]. PfTPx-1 may prevent critical damage to DNA by
ROS and RNS and thus protect the parasite from death
caused by lethal accumulation of mutations [31].
Successful disruption of the PfTPx-1 gene in the parasite
genome indicates that the PfTPx-1 gene is not essential for
parasite survival under in vitro culture conditions and that
there is redundancy in parasite antioxidant defenses. Systems
such as the Trx and GSH systems [5^8] may cooperate with
each other to compensate for the absence of PfTPx-1. Most
likely, other peroxiredoxins, such as PfTPx-2, Pf1-Cys-Prx or
TPxGI, a glutathione peroxidase-like thioredoxin peroxidase
[7], directly compensate for loss of PfTPx-1 function. The
question of how much TPx-1 contributes to malarial parasite
survival in vivo may be interesting to answer. Studies of ro-
dent malaria parasites with TPx-1 gene disruption in mice
may provide some insights.
The results of the present study suggest that 2-Cys Prx of
P. falciparum, PfTPx-1, protects parasite cells from ROS and
RNS. Further studies of the in vivo functions of Prx would
clarify the mechanism underlying parasite adaptation and
may facilitate development of an alternative malaria chemo-
therapy.
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